Maris JM (2010) Recent advances in neuroblastoma. N Engl J Med 362:2202–2211

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma Lancet 369:2106–2120

Article  CAS  PubMed  Google Scholar 

Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, Valteau-Couanet D, Pearson AD, Cohn SL (2015) Advances in risk classification and treatment strategies for Neuroblastoma. J Clin Oncol 33:3008–3017

Article  CAS  PubMed  PubMed Central  Google Scholar 

Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson AD, Force IT (2009) The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 27:298–303

Article  PubMed  PubMed Central  Google Scholar 

Feng L, Lu X, Yang X, Kan Y, Sun D, Wang W, Yang J (2022) An 18F-FDG PET/CT radiomics nomogram for differentiation of high-risk and non-high-risk patients of the International Neuroblastoma Risk Group Staging System. Eur J Radiol 154:110444

Article  PubMed  Google Scholar 

Sato T, Hara K, Ohba G, Yamamoto H, Iguchi A (2021) Long-term survival of two patients with recurrent high-risk neuroblastoma. Pediatr Int 63:849–851

Article  PubMed  Google Scholar 

Bender HG, Irwin MS, Hogarty MD, Castleberry R, Maris JM, Kao PC, Zhang FF, Naranjo A, Cohn SL, London WB (2023) Survival of patients with Neuroblastoma after assignment to reduced therapy because of the 12- to 18-month change in age cutoff in children’s oncology group risk stratification. J Clin Oncol 41:3149–3159

Article  CAS  PubMed  Google Scholar 

Sun Q, Chen Y, Jin Q, Yuan X (2022) A nomogram for predicting recurrence-free survival of intermediate and high-risk neuroblastoma. Eur J Pediatr 181:4135–4147

Article  CAS  PubMed  Google Scholar 

Vallabhajosula S, Nikolopoulou A (2011) Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology. Semin Nucl Med 41:324–333

Article  PubMed  Google Scholar 

Olivier P, Colarinha P, Fettich J, Fischer S, Frökier J, Giammarile F, Gordon I, Hahn K, Kabasakal L, Mann M, Mitjavila M, Piepsz A, Porn U, Sixt R, van Velzen J (2003) Guidelines for radioiodinated MIBG scintigraphy in children. Eur J Nucl Med Mol Imaging 30:B45–50

Article  PubMed  Google Scholar 

Jacobson AF, Deng H, Lombard J, Lessig HJ, Black RR (2010) 123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis. J Clin Endocrinol Metab 95:2596–2606

Article  CAS  PubMed  Google Scholar 

Kiratli PO, Tuncel M, Bar-Sever Z (2016) Nuclear medicine in pediatric and adolescent tumors. Semin Nucl Med 46:308–323

Article  PubMed  Google Scholar 

Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, Giammarile F, Schmidt M, Shulkin BL, Matthay KK, Lewington VJ, Sarnacki S, Hero B, Kaneko M, London WB, Pearson AD, Cohn SL, Monclair T (2011) Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 261:243–257

Article  PubMed  Google Scholar 

Biassoni L, Privitera L (2021) ) 123I-Meta-iodobenzylguanidine single-photon emission computerized tomography/computerized tomography scintigraphy in the management of neuroblastoma. Indian J Nucl Med 36:293–299

Article  PubMed  PubMed Central  Google Scholar 

Feng L, Li S, Wang C, Yang J (2023) Current status and future perspective on molecular imaging and treatment of neuroblastoma. Semin Nucl Med 53:517–529

Article  PubMed  Google Scholar 

Wu Q, Yuan C, Liu N, Shu J, Wang J, Qian J, Zeng L, Zhang H, Wang X, Mei W (2022) Fast detection, a precise and sensitive diagnostic agent for breast cancer. J Exp Clin Cancer Res 41:201

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yanik GA, Parisi MT, Shulkin BL, Naranjo A, Kreissman SG, London WB, Villablanca JG, Maris JM, Park JR, Cohn SL, McGrady P, Matthay KK (2013) Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the children’s oncology group. J Nucl Med 54:541–548

Article  CAS  PubMed  Google Scholar 

Betancur J, Otaki Y, Motwani M, Fish MB, Lemley M, Dey D, Gransar H, Tamarappoo B, Germano G, Sharir T, Berman DS, Slomka PJ (2018) Prognostic value of combined clinical and myocardial perfusion imaging data using machine learning. JACC-Cardiovascular Imaging 11:1000–1009

Article  PubMed  Google Scholar 

Chidambaram S, Sounderajah V, Maynard N, Markar SR (2022) Diagnostic performance of artificial intelligence-centred systems in the diagnosis and postoperative surveillance of upper gastrointestinal malignancies using computed tomography imaging: a systematic review and Meta-analysis of diagnostic accuracy. Ann Surg Oncol 29:1977–1990

Article  PubMed  Google Scholar 

Feng L, Qian L, Yang S, Ren Q, Zhang S, Qin H, Wang W, Wang C, Zhang H, Yang J (2022) Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma. BMC Med Imaging 22:102

Article  PubMed  PubMed Central  Google Scholar 

Feng L, Zhang S, Wang C, Li S, Kan Y, Wang C, Zhang H, Wang W, Yang J (2023) Axial skeleton radiomics of 18F-FDG PET/CT: impact on event-free survival prediction in high-risk pediatric neuroblastoma. Acad Radiol 30:2487–2496

Article  PubMed  Google Scholar 

Feng L, Yang X, Lu X, Kan Y, Wang C, Sun D, Zhang H, Wang W, Yang J (2022) ) 18F-FDG PET/CT-based radiomics nomogram could predict bone marrow involvement in pediatric neuroblastoma. Insights Imaging 13:144

Article  PubMed  PubMed Central  Google Scholar 

Feng L, Qian L, Yang S, Ren Q, Zhang S, Qin H, Wang W, Wang C, Zhang H, Yang J (2022) Prediction for mitosis-karyorrhexis index status of pediatric neuroblastoma via machine learning based 18F-FDG PET/CT radiomics. Diagnostics (Basel) 12

Feng L, Yang X, Lu X, Kan Y, Wang C, Zhang H, Wang W, Yang J (2022) Diagnostic value of 18F-FDG PET/CT-based radiomics nomogram in bone marrow involvement of pediatric neuroblastoma. Acad Radiol 30:940–951

Article  PubMed  Google Scholar 

Chen Q, Pan T, Wang YN, Schoepf UJ, Bidwell SL, Qiao H, Feng Y, Xu C, Xu H, Xie G, Gao X, Tao XW, Lu M, Xu PP, Zhong J, Wei Y, Yin X, Zhang J, Zhang LJ (2023) A coronary CT angiography Radiomics model to identify vulnerable plaque and predict cardiovascular events. Radiology 307:e221693

Article  PubMed  Google Scholar 

Mattonen SA, Davidzon GA, Benson J, Leung ANC, Vasanawala M, Horng G, Shrager JB, Napel S, Nair VS (2019) Bone marrow and tumor radiomics at 18F-FDG PET/CT: impact on outcome prediction in non-small cell lung cancer. Radiology 293:451–459

Article  PubMed  Google Scholar 

Park JR, Kreissman SG, London WB, Naranjo A, Cohn SL, Hogarty MD, Tenney SC, Haas-Kogan D, Shaw PJ, Kraveka JM, Roberts SS, Geiger JD, Doski JJ, Voss SD, Maris JM, Grupp SA, Diller L (2019) Effect of tandem autologous stem cell transplant vs single transplant on event-free survival in patients with high-risk neuroblastoma: a randomized clinical trial. JAMA 322:746–755

Article  PubMed  PubMed Central  Google Scholar 

Stauss J, Franzius C, Pfluger T, Juergens KU, Biassoni L, Begent J, Kluge R, Amthauer H, Voelker T, Højgaard L, Barrington S, Hain S, Lynch T, Hahn K (2008) Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging 35:1581–1588

Article  CAS  PubMed  Google Scholar 

Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ (2015) FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328–354

Article  CAS  PubMed  Google Scholar 

Zhou Z, Wang G, Qian L, Liu J, Yang X, Zhang S, Zhang M, Kan Y, Wang W, Yang J (2023) Evaluation of iodine-123-labeled metaiodobenzylguanidine single-photon emission computed tomography/computed tomography based on the International Society of Pediatric Oncology Europe Neuroblastoma score in children with neuroblastoma. Quant Imag Med Surg 13:3841–3851

Article  Google Scholar 

Liu B, Servaes S, Zhuang H (2018) SPECT/CT MIBG imaging is crucial in the follow-up of the patients with high-risk neuroblastoma. Clin Nucl Med 43:232–238

Article  CAS  PubMed  Google Scholar 

Matthay KK, Edeline V, Lumbroso J, Tanguy ML, Asselain B, Zucker JM, Valteau-Couanet D, Hartmann O, Michon J (2003) Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma. J Clin Oncol 21:2486–2491

Article  PubMed  Google Scholar 

Naranjo A, Parisi MT, Shulkin BL, London WB, Matthay KK, Kreissman SG, Yanik GA (2011) Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer 56:1041–1045

Article  PubMed  PubMed Central  Google Scholar 

Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, Bauer C, Jennings D, Fennessy F, Sonka M, Buatti J, Aylward S, Miller JV, Pieper S, Kikinis R (2012) 3D slicer as an image computing platform for the quantitative Imaging Network. Magn Reson Imaging 30:1323–1341

Article  PubMed  PubMed Central  Google Scholar 

Liu J, Li C, Yang X, Lu X, Zhang M, Qian L, Wang W, Kan Y, Yang J (2022) The Diagnostic Value of 18F-FDG PET/CT Bone Marrow Uptake Pattern in Detecting Bone Marrow Involvement in Pediatric Neuroblastoma Patients. Contrast Media Mol Imaging 2022:7556315

Zhou HF, Han YQ, Lu J, Wei JW, Guo JH, Zhu HD, Huang M, Ji JS, Lv WF, Chen L, Zhu GY, Jin ZC, Tian J, Teng GJ (2019) Radiomics facilitates candidate selection for Irradiation stents among patients with unresectable pancreatic Cancer. Front Oncol 9:973

Article